Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis
Clinical trial NCT02258867 · TERMINATED
Trial details
- NCT number
- NCT02258867
- Sponsor
- XOMA (US) LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-10-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.